Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology

Considerations and approach prior to treatment with 177Lutetium DOTATATE Radionuclide Therapy

Sean Huls, Brian Burkett, Ayse Kendi, Brendan Lunn, Derek Johnson and Ann Packard
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2688;
Sean Huls
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Burkett
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayse Kendi
2Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan Lunn
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek Johnson
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Packard
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 2688

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Sean Huls1,
  2. Brian Burkett1,
  3. Ayse Kendi2,
  4. Brendan Lunn1,
  5. Derek Johnson1 and
  6. Ann Packard1
  1. 1Mayo Clinic
  2. 2Mayo Clinic, Rochester, MN, USA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20221100
Sep 20221000
Oct 2022800
Nov 2022700
Dec 20221500
Jan 20231800
Feb 20231500
Mar 2023500
Apr 2023400
May 2023400
Jun 2023500
Jul 2023200
Aug 2023700
Sep 2023700
Oct 20231200
Nov 2023400
Dec 2023700
Jan 2024800
Feb 2024100
Mar 2024400
Apr 20243100
May 2024600
Jun 20243500
Jul 202410700
Aug 20249400
Sep 20242700
Oct 2024500
Nov 2024900
Dec 2024600
Jan 2025800
Feb 20251000
Mar 2025600
Apr 20251200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Considerations and approach prior to treatment with 177Lutetium DOTATATE Radionuclide Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Considerations and approach prior to treatment with 177Lutetium DOTATATE Radionuclide Therapy
Sean Huls, Brian Burkett, Ayse Kendi, Brendan Lunn, Derek Johnson, Ann Packard
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2688;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Considerations and approach prior to treatment with 177Lutetium DOTATATE Radionuclide Therapy
Sean Huls, Brian Burkett, Ayse Kendi, Brendan Lunn, Derek Johnson, Ann Packard
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2688;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Radioimmunotherapy in Oncology
  • The Role of NAC FDG-PET/CT in Detecting Cutaneous Lesions
  • Quantitative assessment of radiation therapy-induced cardiovascular complications with FDG-PET and NaF-PET imaging in lung cancer and other thoracic malignancies
Show more Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire